Technology Operators Fund II seeks opportunities to work with early and growth stage Arkansas companies in two sectors, software-as-a-service for small businesses and cybersecurity. Typical initial investments are $2 million to $3 million.
Noro-Moseley focuses on high-growth software business serving all industries and on Healthcare Services and Information Technology companies. Particular areas of interest for investing include: security and financial technology, video delivery, cloud migration and services, ecommerce platforms, mobility, consumer-oriented healthcare platforms, revenue cycle management, wellness and prevention, and regulatory compliance management software.
Fulcrum Growth Fund II is actively seeking opportunities to invest in rapidly growing Arkansas companies with a minimum of $3 million in revenue. Fulcrum typically invests $1 to $5 million initially, and up to $10 million in any one company. They consider investments in a wide range of industries with an emphasis on information technology, healthcare, greentech and technology enabled operating companies.
Petra Growth Fund II makes commitments of up to $10 million as junior capital per company. The firm focuses on companies with at least $10 million in revenue and $1 million in ebitda at the time of investment and finances expansion, acquisitions, buyouts or recapitalization for high growth and high margin companies. Target industries include healthcare, software, business outsourcing, information services and media.
The Fund for Arkansas’ Future (FAF) II focuses on investments in seed and early stage companies throughout Arkansas. Investments are often in technology or biotechnology-related companies, though FAF II is not limited to any particular industry.
Fund for Arkansas' Future I and II
P.O. Box 17107
Little Rock, AR 72222
Contact: Jeff Stinson, Executive Director
Meritus Ventures, LP is a $36.4 million venture capital fund formed to make equity investments in private, expansion-stage companies in predominantly rural areas.
Memphis Biomed Ventures II, L.P. invests in the health care industry, including medical device and biotechnology companies with a particular interest in companies developing product solutions for musculoskeletal disease. The fund invests at various stages of development from seed and early stage financings to later-stage deals.
Prolog II seeks a balanced exposure to four key life sciences sectors: biopharmaceuticals, medical technology, agriculture and nutrition, and healthcare information technology. Key selection criteria includes novel functionality, technical validity, the potential for strong intellectual property positions and large accessible markets.
SSMSSM Venture Partners invests in rapidly growing, privately-held companies most often in the business, healthcare, and consumer services industries. SSM is one of the largest and most experienced growth equity firms in the Southeast, having invested in more than 60 companies across five growth equity funds.